HDGF as a Novel Serological Marker for Proliferative Diabetic Retinopathy: A Mendelian Randomization and Cross-Sectional Study
Translational Vision Science & Technology · 22.05.2026 · 15 (5) · 19
DOI: 10.1167/tvst.15.5.19 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Translational Vision Science & Technology, erschienen am 22.05.2026. Verfasst von Yi-Sha Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Biomarkers. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.
- Department of Computer Science, International Digital Economy College of Minjiang University, Fuzhou, Fujian Province, China.
- Engineering Research Centre of Assistive Technology for Visual Impairment, Fujian Province University, Quanzhou, Fujian Province, China.
Zitieren
APA
Zheng, Y. S., Chen, S. Y., Chen, H. X., Liu, W. J., Chen, J. Y., Chen, W. J., Zhang, Y. H., & Hong, Y. (2026). HDGF as a Novel Serological Marker for Proliferative Diabetic Retinopathy: A Mendelian Randomization and Cross-Sectional Study. Translational Vision Science & Technology, 15(5), 19. https://doi.org/10.1167/tvst.15.5.19
Vancouver
Zheng YS, Chen SY, Chen HX, Liu WJ, Chen JY, Chen WJ, et al. HDGF as a Novel Serological Marker for Proliferative Diabetic Retinopathy: A Mendelian Randomization and Cross-Sectional Study. Translational Vision Science & Technology. 2026;15(5):19. doi:10.1167/tvst.15.5.19
BibTeX
@article{Zheng2026,
author = {Zheng, Yi-Sha and Chen, Shu-Yun and Chen, Hong-Xiang and Liu, Wen-Jing and Chen, Jie-Yu and Chen, Wan-Jin and Zhang, Yu-Hao and Hong, Yu},
title = {HDGF as a Novel Serological Marker for Proliferative Diabetic Retinopathy: A Mendelian Randomization and Cross-Sectional Study},
journal = {Translational Vision Science & Technology},
year = {2026},
volume = {15},
number = {5},
pages = {19},
doi = {10.1167/tvst.15.5.19}
}
EUVIMED